Dive in Biomedical Research Funding Slows Patient Cures
/https://static.texastribune.org/media/images/2013/12/10/TxWHP9237ss.jpg)
Federal funding for biomedical research has fallen 22 percent since 2003, dramatically slowing the pace of development for new drugs and treatments. A hoped-for remedy is the 21st Century Cures Act, which would set funding levels and speed drug approvals, according to a North Texas panel of doctors and elected officials address. (Dallas Business Journal)